B3GNT5
Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase
Also known as: B3GN-T5, B3GN5_HUMAN, beta3Gn-T5
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BYG0
- Gene
- B3GNT5
- Ensembl
- ENSG00000176597
- Chromosome
- 3
- Canonical length
- 378 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoli
OverviewNCBI Gene
This gene encodes a member of the beta-1,3-N-acetylglucosaminyltransferase family. This enzyme is a type II membrane protein. It exhibits strong activity to transfer GlcNAc to glycolipid substrates and is identified as the most likely candidate for lactotriaosylceramide synthase. This enzyme is essential for the expression of Lewis X epitopes on glycolipids. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
378 residues, UniProt reviewed canonical sequence.
>Q9BYG0|B3GNT5
1 MRMLVSGRRV KKWQLIIQLF ATCFLASLMF FWEPIDNHIV SHMKSYSYRY LINSYDFVND
61 TLSLKHTSAG PRYQYLINHK EKCQAQDVLL LLFVKTAPEN YDRRSGIRRT WGNENYVRSQ
121 LNANIKTLFA LGTPNPLEGE ELQRKLAWED QRYNDIIQQD FVDSFYNLTL KLLMQFSWAN
181 TYCPHAKFLM TADDDIFIHM PNLIEYLQSL EQIGVQDFWI GRVHRGAPPI RDKSSKYYVS
241 YEMYQWPAYP DYTAGAAYVI SGDVAAKVYE ASQTLNSSLY IDDVFMGLCA NKIGIVPQDH
301 VFFSGEGKTP YHPCIYEKMM TSHGHLEDLQ DLWKNATDPK VKTISKGFFG QIYCRLMKII
361 LLCKISYVDT YPCRAAFILocalizationUniProt · AlphaFold · HPA
Whether an antibody against B3GNT5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 72 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 72 nTPM
- small intestine: 40 nTPM
- duodenum: 36 nTPM
- esophagus: 35 nTPM
- urinary bladder: 23 nTPM
- colon: 21 nTPM
Single-cell type
- esophageal apical cells: 652 nCPM
- neutrophils: 584 nCPM
- ocular epithelial cells: 442 nCPM
- urothelial cells: 382 nCPM
- esophageal suprabasal cells: 342 nCPM
- syncytiotrophoblasts: 321 nCPM
Immune cell
- neutrophil: 5.6 nTPM
- classical monocyte: 1 nTPM
- eosinophil: 1 nTPM
- myeloid DC: 0.7 nTPM
- total PBMC: 0.3 nTPM
- T-reg: 0.2 nTPM
Brain region
- medulla oblongata: 20 nTPM
- white matter: 19 nTPM
- spinal cord: 17 nTPM
- hypothalamus: 16 nTPM
- pons: 16 nTPM
- midbrain: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.49
- gnomAD pLI
- 0.73
- gnomAD missense Z
- 1.05
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 11% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- central nervous system development
- glycolipid biosynthetic process
- glycoprotein biosynthetic process
- glycosphingolipid biosynthetic process
- protein O-linked glycosylation
Molecular functions
- glycosyltransferase activity
- lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads B3GNT5 as an antibody target. Whether an autoantibody or antibody against B3GNT5 could matter depends on whether native B3GNT5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
B3GNT5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label B3GNT5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...